Tăng cao mức SIgA trong huyết thanh có thể phản ánh sự ảnh hưởng của đường ruột không triệu chứng trong viêm khớp vẩy nến trục không hình ảnh và ngoại biên

Hill JS, Lillicrap MS (2013) Arthritis associated with enteric infection. Best Pract Res Clin Rheumatol 17:219–239 Toivanen A, Toivanen P (2004) Reactive arthritis. Best Pract Res Clin Rheumatol 18:689–703 Rudwaleit M (2017) Spondyloarthritides. Internist (Berl) 58:687–701 Romero-Sanchez C, Jaimes DA, Londoño J, de Avila J, Castellanos JE, Bello JM, Bautista W, Valle-Oñate R (2011) Association between Th-17 cytokine profile and clinical features in patients with spondyloarthritis. Clin Exp Rheumatol 29:828–834 Cox CJ, Kempsell KE, Gaston JSH (2003) Investigation of infectious agents associated with arthritis by reverse transcription PCR of bacterial rRNA. Arthritis Res Ther 5:1–8 Pabst O, Cerovic V, Hornef M (2016) Secretory IgA in the coordination of establishment and maintenance of the microbiota. Trends Immunol 37:287–296 Cerutti A, Rescigno M (2008) The biology of intestinal immunoglobulin A responses. Immunity 28:740–750 Corthèsy B (2007) Roundtrip ticket for secretory IgA: role in mucosal homeostasis? J Immunol 178:27–32 Pabst O (2012) New concepts in the generation and functions of IgA. Nat Rev Immunol 12:821–832 Matysiak T, Moura IC, Arcos M et al (2008) Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease. J Exp Med 205:143–154 Rochereau N, Pavot V, Verrier B, Ensinas A, Genin C, Corthésy B, Paul S (2015) Secretory IgA as a vaccine carrier for delivery of HIV antigen to M cells. Eur J Immunol 45:773–779 Granfors K, Toivanen A (1986) IgA-anti-Yersinia antibodies in Yersinia triggered reactive arthritis. Ann Rheum Dis 45:61–65 Salas-Cuestas F, Bautista-Molano W, Bello-Gualtero JM, Arias I, Castillo DM, Chila-Moreno L, Valle-Oñate R, Herrera D, Romero-Sánchez C (2017) Higher levels of secretory IgA are associated with low disease activity index in patients with reactive arthritis and undifferentiated spondyloarthritis. Front Immunol 8:476. https://doi.org/10.3389/fimmu.2017.00476 Jaffar Z, Ferrini ME, Herritt LA, Roberts K (2009) Cutting edge: lung mucosal Th17-mediated responses induce polymeric Ig receptor expression by the airway epithelium and elevate secretory IgA levels. J Immunol 182:4507–4511 Cao AT, Yao S, Gong B, Elson CO, Cong Y (2012) Th17 cells upregulate polymeric Ig receptor and intestinal IgA and contribute to intestinal homeostasis. J Immunol 189:4666–4673 Braun J, Kingsley G, Van der Heijde D, Sieper J (2000) On the difficulties of establishing a consensus on the definition of and diagnostic investigations for reactive arthritis. J Rheumatol 27:2185–2192 Rudwaleit M, Landewé R, van der Heijde D et al (2009) The development of assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis 68:770–776. https://doi.org/10.1136/ard.2009.108217 Rudwaleit M, van der Heijde D, Landewé R et al (2009) The development of assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68:777–783 Paramarta JE, De Rycke L, Ambarus CA, Tak PP, Bacten D (2013) Undifferentiated spondyloarthritis vs ankylosing spondylitis and psoriatic arthritis: a real-life prospective cohort study of clinical presentation and response to treatment. Rheumatology (Oxford) 52:1873–1878 Satsangi J, Silverberg MS, Vermeire S, Colombel JF (2013) The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 55:749–753 Machado PM, Landewé RB, van der Heijde DM (2011) Endorsement of definitions of disease activity states and improvement scores for the Ankylosing Spondylitis Disease Activity Score: results from OMERACT 10. J Rheumatol 38:1502–1506 Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index. J Rheumatol 21:2286–2291 Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, Jenkinson T (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281–2285 Herrera D, Vasquez C, Corthès y B, Franco MA, Angel J (2013) Rotavirus specific plasma secretory immunoglobulin in children with acute gastroenteritis and children vaccinated with an attenuated human rotavirus vaccine. Hum Vaccin Immunother 9:2409–2417 Jacques P, Elewaut D (2008) Joint expedition: linking gut inflammation to arthritis. Mucosal Immunol 1:364–371 Romero-Sánchez C, Bautista-Molano W, Parra V, de Avila J, Rueda JC, Bello-Gualtero JM, Londoño J, Valle-Oñate R (2017) Gastrointestinal symptoms and elevated levels of anti-saccharomyces cerevisiae antibodies are associated with higher disease activity in Colombian patients with spondyloarthritis. Int J Rheumatol 2017:1–8. https://doi.org/10.1155/2017/4029584 Gonzalez T, Malagon C, Guarnizo P, Mosquera AC, Chila-Moreno L, Romero-Sanchez C (2018) Autoantibodies and gastrointestinal symptoms in Colombian children with juvenile idiopathic arthritis. Curr Rheumatol Rev 14:163–171 Silveira LH, Gutièrrez F, Scopelitis E et al (1993) Chlamydia-induced reactive arthritis. Rheum Dis Clin N Am 19:351–362 Aggarwal A, Misra R, Chandrasekhar S, Prasad KN, Dayal R, Ayyagari A (1997) Is undifferentiated seronegative spondyloarthropathy a forme fruste of reactive arthritis. Br J Rheumatol 36:1001–1004 Grauballe PC, Hjelt K, Krasilnikoff PA, Schiøtz PO (1981) ELISA for rotavirus-specific secretory IgA in human sera. Lancet 2:588–589 Zhang J, Xu L, Liu G, Zhao M, Wang H (2008) The level of serum secretory IgA of patients with IgA nephropathy is elevated and associated with pathological phenotypes. Nephrol Dial Transplant 23:207–212 Oortwijn BD, Van der Boog PJM, Roos A et al (2006) A pathogenic role for secretory IgA in IgA nephropathy. Kidney Int 69:1131–1138 Ajene AN, Fischer Walker CL, Black RE (2013) Enteric pathogens and reactive arthritis: a systematic review of Campylobacter, Salmonella and Shigella-associated reactive arthritis. J Health Popul Nutr 31:299–307. https://doi.org/10.3329/jhpn.v31i3.16515 Cowling P, Ebringer R, Ebringer A (1980) Association of inflammation with raised serum IgA in ankylosing spondylitis. Ann Rheum Dis 39:545–549 Van Spriel AB, Leusen JHW, Vilè H, Van De Winkel JGJ (2002) Mac-1 (CD11b/CD18) as accessory molecule for Fc Alpha R (CD89) binding of IgA. J Immunol 169:3831–3820 Mäki-Ikola O, Lahesmaa R, Heesemann J et al (1994) Yersinia-specific antibodies in serum and synovial fluid in patients with Yersinia triggered reactive arthritis. Ann Rheum Dis 53:535–539 Mathias A, Longet S, Corthèsy B (2013) Agglutinating secretory IgA preserves intestinal epithelial cell integrity during apical infection by Shigella flexneri. Infect Immun 81:3027–3034 Badr-el-Din S, Trejdosiewicz K, Heatley V, Losowsky MS (1988) Local immunity in ulcerative colitis: evidence for defective secretory IgA production. Gut 29:1070–1075 Marteau P, Colombel JF, Nemeth J, Vaerman JP, Dive JC, Rambaud JC (1990) Immunological study of histologically non-involved jejunum during Crohn’s disease: evidence for reduced in vivo secretion of secretory IgA. Clin Exp Immunol 80:196–201 Sato A, Hashiguchi M, Toda E, Iwasaki A, Hachimura S, Kaminogawa S (2003) CD11b+ Peyer’s patch dendritic cells secrete IL-6 and induce IgA secretion from naive B cells. J Immunol 171:3684–3690. https://doi.org/10.4049/jimmunol.171.7.3684 Avery DT, Bryant VL, Ma CS, de Waal Malefyt R, Tangye SG (2008) IL-21-induced isotype switching to IgG and IgA by human naive B cells is differentially regulated by IL-4. J Immunol 181:1767–1779. https://doi.org/10.4049/jimmunol.181.3.1767 Marijnissen RJ, Roeleveld DM, Young D, Nickerson-Nutter C, Abdollahi-Roodsaz S, Garcia de Aquino S, van de Loo FAJ, van Spriel AB, Boots AMH, van den Berg WB, Koenders MI (2014) Interleukin-21 receptor deficiency increases the initial toll-like receptor 2 response but protects against joint pathology by reducing Th1 and Th17 cells during streptococcal cell wall arthritis. Arthritis Rheum 66:886–895 Mantis NJ, Rol N, Corthèsy B (2011) Secretory IgA’s complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunol 4:603–611 Smits HH, Gloudemans AK, Van Nimwegen M et al (2009) Cholera toxin B suppresses allergic inflammation through induction of secretory IgA. Mucosal Immunol 2:331–339 Boulier S, Tanguy M, Kadaoui KA et al (2009) Secretory IgA-mediated neutralization of Shigella flexneri prevents intestinal tissue destruction by down-regulating inflammatory circuits. J Immunol 183:5879–5885